# MIRUM PHARMACEUTICALS INC (MIRM)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/MIRM/

- Reporting holders: 6
- Reported value: $573.1K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [JUNCTURE WEALTH STRATEGIES, LLC](https://holderbook.com/funds/1632866-juncture-wealth-strategies-llc/) | $455.6K | 5,330 | 0.1% | 2 |
| [TOTH FINANCIAL ADVISORY CORP](https://holderbook.com/funds/866780-toth-financial-advisory-corp/) | $58.6K | 685 | 0.0% | 2 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $35.5K | 415 | 0.0% | 11 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $12.3K | 144 | 0.0% | 6 |
| [MassMutual Private Wealth & Trust, FSB](https://holderbook.com/funds/1103653-massmutual-private-wealth-trust-fsb/) | $7.4K | 86 | 0.0% | 10 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $3.8K | 44 | 0.0% | 10 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 6 | $573.1K |
| Q2 2026 | 331 | $8.7B |
| Q1 2026 | 312 | $6.4B |
| Q4 2025 | 284 | $4.9B |
| Q3 2025 | 274 | $4.3B |
| Q2 2025 | 216 | $2.8B |
| Q1 2025 | 217 | $2.5B |
| Q4 2024 | 207 | $2.2B |
| Q3 2024 | 183 | $2.1B |
| Q2 2024 | 166 | $1.8B |
| Q1 2024 | 172 | $1.4B |
| Q4 2023 | 189 | $1.5B |